10-Q: Horizon Finance Reports Q3 Loss Amid Market Headwinds

Horizon Technology Finance Corporation reported a net decrease in net assets for the nine months ended September 30, 2025, driven by significant unrealized depreciation and realized losses on investments, despite strategic merger plans.

Summary

• Net assets decreased by $11.49 million for the nine months ended September 30, 2025, compared to a net increase of $6.80 million in the prior year period.
• Net asset value per common share declined to $7.12 as of September 30, 2025, from $8.43 at December 31, 2024.
• Total investment income slightly decreased by 1.3% to $75.35 million for the nine months ended September 30, 2025, from $76.37 million in the prior year period.
• Net investment income decreased by 3.2% to $36.16 million for the nine months ended September 30, 2025, compared to $37.36 million in the prior year period.
• Realized losses on investments totaled $33.86 million for the nine months ended September 30, 2025, up from $31.42 million in the prior year period.
• Unrealized depreciation on investments was $13.80 million for the nine months ended September 30, 2025, a significant shift from $0.86 million in appreciation in the prior year period.
• The company's total return based on market value was -21.1% for the nine months ended September 30, 2025, compared to -11.2% for the prior year period.
• Four debt investments were on non-accrual status as of September 30, 2025, with an aggregate cost of $61.3 million and a fair value of $29.3 million.
• The weighted average credit rating of the debt investment portfolio deteriorated to 2.9 as of September 30, 2025, from 3.1 at December 31, 2024.
• The 2022 Asset-Backed Notes were fully repaid as of September 30, 2025, accelerating $0.9 million in unamortized debt issuance costs.
• Issued $40.0 million aggregate principal of 5.50% convertible notes due 2030 on September 4, 2025, generating net proceeds of approximately $36.6 million.
• Purchased a portfolio of debt and related investments from Powerscourt XXV LP for $22.5 million on August 6, 2025, with assets having a fair value of $36.5 million at purchase date.
• The company's asset coverage for borrowed amounts was 174% as of September 30, 2025, exceeding the 150% regulatory requirement.

Sentiment

Score: 3

Explanation: The company reported a net decrease in net assets, significant unrealized depreciation, and increased realized losses, leading to a substantial decline in NAV per share and negative total return. While strategic moves like the merger and new debt issuance are underway, the underlying financial performance and portfolio quality have deteriorated, reflecting challenging market conditions for its investments.

Positives

• Total investment income increased by $1.8 million, or 7.1%, for the three months ended September 30, 2025, compared to the prior year period.
• Fee income increased by $0.6 million, or 46.7%, for the three months ended September 30, 2025, primarily due to higher principal prepayments.
• The dollar-weighted annualized yield on debt investments increased to 16.4% for the nine months ended September 30, 2025, from 15.8% in the prior year period.
• The dollar-weighted annualized yield on all investments increased to 15.1% for the nine months ended September 30, 2025, from 14.8% in the prior year period.
• The company successfully issued $40.0 million in 5.50% convertible notes due 2030, enhancing capital resources.
• The acquisition of a $36.5 million fair value portfolio from Powerscourt XXV LP for $22.5 million on August 6, 2025, represents a strategic investment.
• The company maintains strong asset coverage of 174% for borrowed amounts, well above the 150% regulatory minimum.
• Unfunded commitments decreased to $109.0 million as of September 30, 2025, from $181.0 million at December 31, 2024, indicating reduced future funding obligations.

Negatives

• Net decrease in net assets resulting from operations of $11.49 million for the nine months ended September 30, 2025, a significant decline from a $6.80 million increase in the prior year period.
• Net asset value per common share decreased to $7.12 as of September 30, 2025, from $8.43 at December 31, 2024.
• Net unrealized depreciation on investments of $13.80 million for the nine months ended September 30, 2025, contrasts sharply with $0.86 million in appreciation in the prior year period.
• Net realized losses on investments increased to $33.86 million for the nine months ended September 30, 2025, from $31.42 million in the prior year period.
• The total return based on market value was -21.1% for the nine months ended September 30, 2025, indicating poor stock performance.
• The weighted average credit rating of the debt investment portfolio deteriorated to 2.9 as of September 30, 2025, from 3.1 at December 31, 2024, suggesting increased risk in the portfolio.
• Four debt investments were on non-accrual status as of September 30, 2025, with an increased aggregate cost of $61.3 million and fair value of $29.3 million, compared to $44.8 million cost and $10.5 million fair value at December 31, 2024.
• Distributions declared per share decreased to $0.99 for the nine months ended September 30, 2025, from $1.04 in the prior year period, with a potential for further reduction in Q1 2026.

Risks

• The proposed merger with Monroe Capital Corporation (MRCC) is subject to customary closing conditions, including stockholder approvals, and its termination could result in adverse consequences such as lost opportunities, declining stock price, and unrecovered expenses.
• The market price of common stock may be significantly affected by factors beyond control, including volatility in the BDC sector, changes in regulatory policies, loss of RIC/BDC qualification, and changes in portfolio investment values.
• Upon closing the merger, the company expects to receive approximately $165 million in cash proceeds, which must be deployed into suitable investments; failure to do so efficiently could diminish returns.
• The company is exposed to interest rate risk, with 100% of debt investments bearing floating rates as of September 30, 2025, meaning rising rates could increase the cost of funds and reduce net investment income.
• Persistent inflationary pressures, foreign currency exchange volatility, and global capital market volatility could affect portfolio companies' profit margins.
• The valuation of investments, particularly Level 3 assets, involves inherent uncertainty and significant management judgment, and actual realized values may differ materially from recorded fair values.
• Concentration of credit risk exists in technology, life science, healthcare information and services, and sustainability industries, making the company susceptible to adverse developments in these sectors.
• Many portfolio companies are development-stage with limited operating histories, requiring additional capital to meet working capital needs and debt service, which may be challenging in a difficult equity fundraising market.
• There is a risk that distributions to stockholders may be deemed a return of capital for U.S. federal income tax purposes if taxable earnings fall below total distributions.

Future Outlook

The company anticipates that its current cash, cash generated from operations, and available funds from Credit Facilities will be sufficient to meet working capital and capital expenditure commitments for at least the next 12 months. The Board will determine future distribution amounts in February 2026, considering Q4 2025 operating results, spillover income, and the anticipated merger with MRCC, which could lead to lower distributions than those declared in Q4 2025.

Management Comments

• "We believe that our current cash, cash generated from operations, and funds available from our Credit Facilities will be sufficient to meet our working capital and capital expenditure commitments for at least the next 12 months."
• "The Board will determine the next amount of distributions in February 2026, when it will have the Company's operating results for the fourth quarter of 2025, its spillover income at December 31, 2025 and have more clarity on its planned operating results for fiscal year 2026, which will take into account the impact of its anticipated merger with MRCC. This could result in a declaration of distributions lower than the distribution level declared in the fourth quarter of 2025."

Industry Context

The company operates in a challenging environment characterized by a 'difficult equity fundraising market' and 'underperformance of certain portfolio companies,' which has contributed to significant unrealized depreciation. This reflects broader market headwinds impacting venture-backed companies, particularly in the technology, life science, and sustainability sectors. The proposed merger with Monroe Capital Corporation indicates a trend towards consolidation within the Business Development Company (BDC) sector, potentially seeking scale and diversified portfolios to navigate market volatility.

Comparison to Industry Standards

• The weighted average credit rating of the debt investment portfolio deteriorated to 2.9 from 3.1, indicating a decline in portfolio quality compared to previous periods, which may be indicative of broader stress in the venture debt market.
• The significant net unrealized depreciation on investments and increased non-accrual investments suggest that the company's portfolio companies are facing greater financial distress, potentially underperforming relative to general industry expectations for venture-backed firms in the current economic climate.
• The total return based on market value of -21.1% for the nine months ended September 30, 2025, is a substantial underperformance, likely reflecting both company-specific challenges and broader market sentiment towards BDCs or the venture debt asset class.

Corporate Governance

Legal Proceedings

• Not currently subject to any material legal proceedings, nor are any material legal proceedings threatened against the company.

Related Party Transactions

• The company has an Investment Management Agreement and an Administration Agreement with Horizon Technology Finance Management LLC (the Advisor), which is a related party.
• The Advisor receives a base management fee (2.00% of gross assets less cash, with 1.60% on amounts over $250 million) and an incentive fee (20.00% of Pre-Incentive Fee Net Investment Income above a 1.75% hurdle rate, subject to a cap and deferral mechanism).
• The Advisor's indirect parent company, Monroe Capital Intermediate Holdings, LLC, underwent a change of control on March 31, 2025, with Momentum US Bidco LLC acquiring 75% of its equity interests.
• The company relies on exemptive relief from the SEC to co-invest with other investment vehicles managed by the Advisor, Monroe, and their affiliates.
• The Advisor agreed to waive a portion of its quarterly income incentive fee if net investment income per share falls below the quarterly distribution per share, effective from Q1 2025 to Q4 2025.

Stakeholder Impact

• Shareholders: Experienced a significant decrease in Net Asset Value per share and a negative total return. Distributions per share decreased, with a potential for further reductions. The merger with MRCC could lead to dilution and changes in the combined company's risk profile and investment strategy.
• Creditors: The company maintains strong asset coverage (174%), indicating a solid position to meet its debt obligations, despite increased interest expense and some non-accrual investments.
• Portfolio Companies: The 'difficult equity fundraising market' and 'underperformance' of some companies indicate financial stress, potentially impacting their ability to meet debt service obligations to Horizon.

Next Steps

• Complete the proposed merger with Monroe Capital Corporation (MRCC), subject to stockholder approvals and other conditions.
• Deploy approximately $165 million in cash proceeds expected from the merger into new investments consistent with the company's strategy.
• The Board will determine Q1 2026 distributions in February 2026, potentially leading to lower distributions.
• Continue to manage and monitor the portfolio, particularly investments on non-accrual status and those with deteriorating credit ratings.
• Monitor the new exemptive relief application filed by Monroe and the Advisor with the SEC.

Key Dates

Recommendation

The company's financial performance for the nine months ended September 30, 2025, shows significant deterioration, with a net decrease in net assets, substantial unrealized depreciation, and a decline in NAV per share. The total return based on market value is deeply negative. While the proposed merger with Monroe Capital Corporation and recent capital raises (convertible notes, ATM program) are strategic moves to enhance capital and scale, the immediate outlook is clouded by challenging market conditions for venture-backed companies, increased non-accrual investments, and a deteriorating portfolio credit rating. The uncertainty surrounding the merger's completion and the effective deployment of its proceeds, coupled with potential lower future distributions, suggests a 'hold' recommendation. Investors should await more clarity on the merger's impact and a stabilization of portfolio performance before making further investment decisions.

Keywords

Venture Debt, BDC, Business Development Company, SEC Filing, 10-Q, Technology Finance, Life Science Investments, Healthcare Information Services, Sustainability Investments, Monroe Capital Merger, Convertible Notes, Portfolio Performance, Net Asset Value, Unrealized Depreciation, Credit Risk, Interest Rate Risk, Capital Raise, Distributions